Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  74 results for ""Hydroxycholecalciferols""

Your Filters

Subject : uremia
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men.

  • Authors : Brandi L; Nephrological Department P, Rigshospitalet, University of Copenhagen, Denmark. ; Egfjord M

Subjects: Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*pharmacokinetics ; Steroid Hydroxylases/Steroid Hydroxylases/Steroid Hydroxylases/*pharmacokinetics ; Uremia/Uremia/Uremia/*blood

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2002 May; Vol. 17 Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium: Print ISSN: 0931-0509

Record details

Read More Add to Saved list
×
Academic Journal

A comparison of oral and intravenous alfacalcidol in the treatment of uremic hyperparathyroidism.

  • Authors : Lee WT; Department of Medicine, Auckland Hospital, New Zealand.; Padayachi K

Subjects: Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*administration & dosage ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy ; Uremia/Uremia/Uremia/*complications

  • Source: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 1994 Dec; Vol. 5 (6), pp. 1344-8.Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.

  • Authors : Brandi L; Nephrological Department P, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. ; Egfjord M

Subjects: Calcitriol/Calcitriol/Calcitriol/*pharmacology ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*pharmacology ; Parathyroid Hormone/Parathyroid Hormone/Parathyroid Hormone/*blood

  • Source: Nephron. Clinical practice [Nephron Clin Pract] 2005; Vol. 99 (4), pp. c128-37. Date of Electronic Publication: 2005 Feb 17.Publisher: Karger Country of Publication: Switzerland NLM ID: 101159763 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Combined therapy with calcitonin and high doses of active vitamin D3 metabolites in uremic hyperparathyroidism].

Subjects: Calcitonin/Calcitonin/Calcitonin/*therapeutic use ; Calcitriol/Calcitriol/Calcitriol/*therapeutic use ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use

  • Source: Polskie Archiwum Medycyny Wewnetrznej [Pol Arch Med Wewn] 1996 Jul; Vol. 96 (1), pp. 23-31.Publisher: Medycyna Praktyczna Country of Publication: Poland NLM ID: 0401225 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation:

Record details

Read More Add to Saved list
×
Academic Journal

Intermittent intravenous followed by intermittent oral 1 alpha(OH)D3 treatment of secondary hyperparathyroidism in uraemia.

  • Authors : Brandi L; Medical Department P, Rigshospitalet, University of Copenhagen, Denmark.; Daugaard H

Subjects: Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy ; Kidney Failure, Chronic/Kidney Failure, Chronic/Kidney Failure, Chronic/*complications

  • Source: Journal of internal medicine [J Intern Med] 1996 Apr; Vol. 239 (4), pp. 353-60.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Control of severe hyperparathyroidism and regression of a brown tumour after treatment with i.v. alfacalcidol in a uraemic patient.

Subjects: Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy ; Lipoma/Lipoma/Lipoma/*therapy

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 1996 Jan; Vol. 11 Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium: Print ISSN: 0931-0509

Record details

Read More Add to Saved list
×
Academic Journal

Control of severe hyperparathyroidism and regression of a brown tumour after treatment with i.v. alfacalcidol in a uraemic patient.

  • Authors : Mourad G; Department of Nephrology, University Hospital Lapeyronie, Montpellier, France.; Argilés A

Subjects: Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy ; Maxillary Diseases/Maxillary Diseases/Maxillary Diseases/*drug therapy

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 1995; Vol. 10 (4), Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium: Print ISSN: 0931-0509

Record details

Read More Add to Saved list
×
Academic Journal

1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.

Subjects: Bone Diseases/Bone Diseases/Bone Diseases/*complications ; Bone Diseases/Bone Diseases/Bone Diseases/*drug therapy ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use

  • Source: Nephron [Nephron] 1995; Vol. 71 (3), pp. 254-83.Publisher: Karger Country of Publication: Switzerland NLM ID: 0331777 Publication Model: Print Cited Medium: Print ISSN: 1660-8151 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Oral pulsatile therapy with active vitamin D3 metabolites--an efficient method of parathyroid hormone synthesis suppression in uremic patients with severe hyperparathyroidism. A pilot study].

Subjects: Calcitriol/Calcitriol/Calcitriol/*administration & dosage ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*administration & dosage ; Hyperparathyroidism/Hyperparathyroidism/Hyperparathyroidism/*drug therapy

  • Source: Polskie Archiwum Medycyny Wewnetrznej [Pol Arch Med Wewn] 1993 Feb; Vol. 89 (2), pp. 95-101.Publisher: Medycyna Praktyczna Country of Publication: Poland NLM ID: 0401225 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation:

Record details

Read More Add to Saved list
×
Academic Journal

Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.

Subjects: Chronic Kidney Disease-Mineral and Bone Disorder/Chronic Kidney Disease-Mineral and Bone Disorder/Chronic Kidney Disease-Mineral and Bone Disorder/*drug therapy ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use ; Uremia/Uremia/Uremia/*drug therapy

  • Source: Annals of internal medicine [Ann Intern Med] 1981 Mar; Vol. 94 (3), pp. 404-5.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print

Record details

Read More Add to Saved list
×
  • 1-10 of  74 results for ""Hydroxycholecalciferols""